| Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift |
18 |
| Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes |
17 |
| Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases |
14 |
| Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: Implications for clinical practice |
12 |
| Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function |
10 |
| Dipeptidyl peptidase-4 inhibitors and cardiovascular and renal disease in type 2 diabetes: What have we learned from the CARMELINA trial? |
10 |
| Leptin/adiponectin ratio in overweight patients - gender differences |
10 |
| Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studies |
9 |
| Effects of sodium glucose co-transporter 2 inhibitors on the kidney |
9 |
| Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis |
9 |
| The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis |
8 |
| Microvascular complications among patients with diabetes: An emerging health problem in Saudi Arabia |
8 |
| Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial |
8 |
| Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome |
7 |
| Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease |
7 |
| Haemoglobin A1c variability as an independent correlate of atherosclerosis and cardiovascular disease in Chinese type 2 diabetes |
6 |
| Impact of race/ethnicity on insulin resistance and hypertriglyceridaemia |
6 |
| Effects of magnitude of visceral adipose tissue reduction: Impact on insulin resistance, hyperleptinemia and cardiometabolic risk in adolescents with obesity after long-term weight-loss therapy |
6 |
| Serum sclerostin in vascular calcification and clinical outcome in chronic kidney disease |
6 |
| Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial |
6 |
| Increased erythrocyte- and platelet-derived microvesicles in newly diagnosed type 2 diabetes mellitus |
6 |
| Optimising use of rate-of-change trend arrows for insulin dosing decisions using the FreeStyle Libre flash glucose monitoring system |
5 |
| Probucol prevents blood-brain barrier dysfunction and cognitive decline in mice maintained on pro-diabetic diet |
5 |
| Impact of diabetes type on treatment and outcome of patients with peripheral artery disease |
5 |
| How sensitive and specific is continuous-wave Doppler for detecting peripheral arterial disease in people with and without diabetes? A cross-sectional study |
5 |
| Blood urea nitrogen and risk of insulin use among people with diabetes |
5 |
| Cardiovascular outcomes in patients who experienced a myocardial infarction while treated with liraglutide versus placebo in the LEADER trial |
5 |
| Association between 1-h post-load plasma glucose levels and arterial stiffness in normotensive subjects with normal glucose tolerance |
5 |
| High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide report |
5 |
| Increased plasma FGF21 level as an early biomarker for insulin resistance and metabolic disturbance in obese insulin-resistant rats |
4 |
| Association of central arterial stiffness with the presence and severity of diabetic retinopathy in Asians with type 2 diabetes |
4 |
| Performance of plasminogen activator inhibitor-1 as a biomarker in patients undergoing coronary angiography: Analytical and biological considerations |
4 |
| Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients |
4 |
| Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes |
4 |
| Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial |
4 |
| A longitudinal study of choroidal changes following cataract surgery in patients with diabetes |
4 |
| Downregulation of MicroRNA 29a/b exacerbated diabetic retinopathy by impairing the function of Muller cells via Forkhead box protein O4 |
4 |
| Long non-coding RNA nuclear paraspeckle assembly transcript 1 inhibits the apoptosis of retina Muller cells after diabetic retinopathy through regulating miR-497/brain-derived neurotrophic factor axis |
4 |
| Echocardiographic association of epicardial fat with carotid intima-media thickness in patients with type 2 diabetes |
4 |
| Effect of bariatric surgery on diabetic nephropathy in obese type 2 diabetes patients in a retrospective 2-year study: A local pilot |
4 |
| The combined effect of vitamin D and parathyroid hormone concentrations on glucose homeostasis in older patients with prediabetes: A cross-sectional study |
4 |
| An analysis of barriers to entry of cardiac rehabilitation in patients with diabetes: Using data from the National Audit of Cardiac Rehabilitation |
4 |
| Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients |
4 |
| Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries |
4 |
| The relationship of perivascular adipose tissue and atherosclerosis in the aorta and carotid arteries, determined by magnetic resonance imaging |
4 |
| Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney disease |
4 |
| Interobserver reliability of the ankle-brachial index, toe-brachial index and distal pulse palpation in patients with diabetes |
4 |
| Diabetes-induced early molecular and functional changes in aortic heart valves in a murine model of atherosclerosis |
4 |
| Hyperglycaemia correlates with skeletal muscle capillary regression and is associated with alterations in the murine double minute-2/forkhead box O1/thrombospondin-1 pathway in type 1 diabetic BioBreeding rats |
3 |
| Microarray analysis of long non-coding RNA and mRNA expression profiles in diabetic cardiomyopathy using human induced pluripotent stem cell-derived cardiomyocytes |
3 |
